🔎 Trials Near Me

Home › NCT07066709

Painful Post-Operative Hip Study

RecruitingPhase 2

Identifying and Managing Pain Generators in Patients With Persistent Post-hip Arthroscopy Pain Using FDG PET/MRI

Who can join

Ages 18 to 45 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Age 18-45
* History of unilateral hip arthroscopy
* Does not have evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy
* Does not have evidence of depression or other major mental health conditions before the index hip arthroscopy
* Does not have persistent pain that requires opioid use, or does not have a history of opioid abuse
* Does not have any comorbidity results in systemic disease limiting function (ASA physical status classification \>3)
* Not currently pregnant
* Presents with persistent pain (≥4/10 on NRS) for at least 6 months post-hip arthroscopy
* Undergo a revision hip arthroscopy with no surgical history on the contralateral limb

Exclusion Criteria:

* No unilateral hip arthroscopy
* Evidence of fracture, infection, or malignancy at 6 months post-hip arthroscopy
* Evidence of depression or other major mental health conditions before the index hip arthroscopy
* Has persistent pain that requires opioid use, or has a history of opioid abuse
* Has any comorbidity results in systemic disease limiting function (ASA physical status classification \<3)
* Currently pregnant

About the study

The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management.

Participants will complete one PET/MRI scan.

What is being tested

Sponsor: University of Wisconsin, Madison · Participants: 15 · Started: Jan 21, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07066709

Locations in the U.S.

WisconsinUniversity of Wisconsin - Madison, Madison

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.